STAT July 1, 2024
Ed Silverman

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because the familiar routine of online meetings, calls, and deadlines has predictably returned. But you know, the world — such as it is — continues to spin. So what can you do but try to give it a nudge in a better direction. To make this happen, we are brewing cups of stimulation. Our choice today is toasted almond caramel. Please feel free to join us. Meanwhile, here are a few tidbits to get you going. We hope you have a grand day and, as always, do keep in touch. Our settings are now adjusted to accept telegrams and postcards. …

The...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
STAT+: Pharmalittle: We’re reading about FTC probing Teva patents, a Moderna flu vaccine contract, and more
Mean cost of bringing new drug to US market is $879.3 million, study estimates
PrimeRx Intros Online Marketplace for Pharmacies
STAT+: Report shows U.S. biotechs are wary of Chinese partnerships due to looming BIOSECURE Act
Research Reveals US Regions With Highest Drugstore Closures

Share This Article